Porter Novelli, in partnership with Quantum Market Research, has unveiled Winds of Change: Regional Australians’ Real Views on Renewables, a new research study revealing strong regional support ...

Dezeen Showroom: workplace furniture brand Narbutas worked with Italian design studio Baldanzi & Novelli on a range of seating that sets out to enhance the wellbeing of people working in office ...

GlaxoSmithKline ( (GSK)) has realeased its Q3 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors. GlaxoSmithKline (GSK) is a global biopharmaceutical ...

Kepler Capital analyst David Evans maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) on October 30 and set a price target of p1,500.00. The company’s shares closed yesterday ...

If the market demands a combustion-powered Giulia, Alfa Romeo could provide it. The next-generation model will be underpinned by the Stellantis STLA Large architecture. A successor to the range ...

GlaxoSmithKline (GSK) has released an update. GlaxoSmithKline (GSK) has announced that its issued share capital as of October 31, 2024, consists of over 4.3 billion ordinary shares, with a total ...

Moderna to defend against GSK's claims, spokesperson says GSK seeks unspecified monetary damages from Moderna A spokesperson for Massachusetts-based Moderna said the company was aware of the ...

Oct 29 (Reuters) - India's GlaxoSmithKline Pharmaceuticals (GLAX.NS), opens new tab reported a higher second-quarter adjusted profit on Tuesday, driven by strong demand for its generic drugs and ...

Giulia Carbonaro is a Newsweek Reporter based in London, U.K. Her focus is on U.S. and European politics, global affairs and housing. She has covered the ups and downs of the U.S. housing market ...

The market for four-door performance sedans is becoming increasingly thin in 2024, as greater focus is placed on making high-riding SUVs go really fast. Of course, the segment stalwarts remain.

GlaxoSmithKline said its key brands held their market share and continued to stay in line with the respective category performance. GlaxoSmithKline Pharmaceuticals on October 29 reported a 16 ...

By Blake Brittain (Reuters) -British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of violating GSK patent rights in messenger RNA technology ...